Fresenius | FRE - Equity Capital And Reserves


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Fresenius

Fresenius reported EUR20.53B in Equity Capital and Reserves for its fiscal quarter ending in March of 2023.


Equity Capital And Reserves Change
Akzo Nobel AKZA:NA EUR 4.42B 86M
Alcon AG ALC:SW USD 19.86B 187M
AstraZeneca AZN:LN USD 35.79B 1.25B
BASF BAS:GR EUR 40.69B 1.12B
Bayer BAYN:GR EUR 40.86B 2.09B
DaVita Healthcare Partners DVA:US USD 825.47M 113.14M
Demant A/s WDH:DC DKK 8.56B 382M
E.ON EOAN:GR EUR 15.86B 65M
Essilor EI:FP EUR 37.46B 363M
Fresenius FRE:GR EUR 20.53B 117M
Getinge GETIB:SS SEK 30.63B 595M
Givaudan GIVN:VX CHF 4.23B 216M
GlaxoSmithKline GSK:LN GBP 11.82B 1.22B
GN Store Nord GN:DC DKK 6.63B 170M
Hikma Pharmaceutical HIK:LN USD 2.14B 41M
Lonza Group LONN:SW CHF 10.6B 586M
Merck MRK:GR EUR 26.15B 222M
Novartis NOVN:VX USD 52.06B 7.28B
Roche Holding ROG:VX 27.99B 2.8B
RWE RWE:GR EUR 32.09B 4.51B
Smith & Nephew PLC SN/:LN 5.26B 136M